Loading resource…

ESC Working Group on Thrombosis, Association for Acute CardioVascular Care of the ESC, European Association of Percutaneous Cardiovascular Interventions of the ESC, ESC Working Group on Cardiovascular Pharmacology
This document is a clinical consensus statement from multiple ESC working groups and associations, focusing on antithrombotic therapy following acute coronary syndromes (ACS) and percutaneous coronary intervention (PCI). It highlights the risks associated with standard dual antiplatelet therapy (DAPT) and explores personalized options to mitigate bleeding or ischaemic events. The statement discusses therapeutic strategies, including the addition of very low dose rivaroxaban, and considers patient profiles to optimize treatment outcomes.
No account needed
Answers use this document only.
Resources from the same specialty and type. Curated links will replace these when added.
Documents that extend or complement this resource.

CRITERIA FOR THE DIAGNOSIS OF CARDIOGENIC SHOCK—EUROPEAN PERSPECTIVE: A CLINICAL CONSENSUS STATEMENT
Same clinical topic · Cardiology

2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Same clinical topic · Cardiology

2025 ACC Scientific Statement on the Management of Obesity in Adults With Heart Failure
Same clinical topic · Cardiology

2025 AHA/ACC Guideline for the Management of High Blood Pressure in Adults
Same clinical topic · Cardiology

2026 ESC GUIDELINES FOR THE MANAGEMENT OF CARDIOVASCULAR DISEASE AND CHRONIC KIDNEY DISEASE
Same clinical topic · Cardiology

2026 AHA/ACC/ACCP/ACEP/CHEST/SCAI/SHM/SIR/SVM/SVN Guideline for the Evaluation and Management of Acute Pulmonary Embolism in Adults
Same clinical topic · Cardiology

2026 ESC GUIDELINES FOR THE MANAGEMENT OF HEART FAILURE
Same clinical topic · Cardiology

MANAGEMENT OF ACUTE CORONARY SYNDROME
Same clinical topic · Cardiology

Guidelinefor the Prevention, Detection,Evaluation, and Management
Same clinical topic · Cardiology